News

Filter

Current filters:

Revestive

Takeda's Revestive gets EU clearance for short bowel syndrome

05-09-2012

Japan's largest drugmaker Takeda Pharmaceutical (TSE: 4502) and partner NPS Pharmaceuticals (Nasdaq:…

EuropeGastro-intestinalsNPS PharmaceuticalsPharmaceuticalRegulationRevestiveTakeda Pharmaceuticals

NPS Pharma posts overall positive Gattex data, but shares plunge due to two deaths

01-11-2011

Shares in USA-based NPS Pharmaceuticals (Nasdaq: NPSP) plummeted as much as 38% to $4.92 in morning trading…

Gastro-intestinalsGattexNPS PharmaceuticalsNycomedPharmaceuticalResearchRevestive

Nycomed files for EU appro of SBS drug Revestive

29-03-2011

Privately-held Swiss drugmaker Nycomed has submitted a Marketing Authorization Application (MAA) to the…

EuropeGastro-intestinalsNPS PharmaceuticalsNycomedPharmaceuticalRare diseasesRegulationRevestiveteduglutide

Back to top